Cases & Deals

  • Home
  • Practices
  • Pharmaceutical and device manufacturers advised on Physician Payments Sunshine Act

Share

Pharmaceutical and device manufacturers advised on Physician Payments Sunshine Act

June 2013

Client(s) Pharmaceutical and device manufacturers

Jones Day has been advising several pharmaceutical and device manufacturers on the reporting of payments or other transfers of value under the Physician Payments Sunshine Act, including analysis of specific scenarios involving subsidiaries, foreign and domestic, co-development arrangements, research activities, licensing and material transfer arrangements, and other payments or transfers of value related to covered recipients.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.